Zura Bio Limited (ZURA)
NASDAQ: ZURA · Real-Time Price · USD
2.280
-0.060 (-2.56%)
At close: Dec 20, 2024, 4:00 PM
2.320
+0.040 (1.75%)
After-hours: Dec 20, 2024, 4:07 PM EST
Zura Bio Stock Forecast
ZURA's stock price has decreased by -54.4% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Zura Bio stock have an average target of 15.8, with a low estimate of 5.00 and a high estimate of 26. The average target predicts an increase of 592.98% from the current stock price of 2.28.
Analyst Consensus: Buy
* Price targets were last updated on Nov 18, 2024.
Analyst Ratings
The average analyst rating for Zura Bio stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 1 | 1 | 0 | 1 | 1 |
| Buy | 4 | 4 | 3 | 3 | 4 | 4 |
| Hold | 0 | 0 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 5 | 5 | 4 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Dec 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $5 | Hold | Reiterates | $5 | +119.30% | Nov 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $5 | Hold | Reiterates | $5 | +119.30% | Nov 11, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $14 → $12 | Strong Buy | Maintains | $14 → $12 | +426.32% | Nov 8, 2024 |
| Leerink Partners | Leerink Partners | Buy Initiates $15 | Buy | Initiates | $15 | +557.89% | Nov 4, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.67
from -2.09
EPS Next Year
-0.76
from -0.67
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | n/a | n/a | 26.3M |
| Avg | n/a | n/a | 4.3M |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.61 | -0.42 | -0.64 |
| Avg | -0.67 | -0.76 | -0.96 |
| Low | -0.71 | -1.37 | -1.71 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.